m+Medelevator.RU
← Поиск публикаций
Archives of otolaryngology--head & neck surgery · 1996

Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kowalski L P, Batista M B, Santos C R, Scopel A, Salvajolli J V, Torloni H

Аннотация

OBJECTIVE: To evaluate prognostic factors in patients with T3,N0-1 glottic and transglottic carcinoma treated in a single institution.

DESIGN: Retrospective, nonrandomized case series.

SETTING: Tertiary case referral centers, ambulatory or hospitalized care.

PATIENTS: Two hundred twenty-one consecutive cases of stage III glottic or transglottic squamous cell carcinoma. Tumor stage was T3,N0,M0 in 167 cases and T3,N1,M0 in 54 cases.

INTERVENTIONS: Surgery in 176 cases and radiotherapy in 45 cases.

MAIN OUTCOME MEASURES: Recurrences and survival (multivariate).

RESULTS: Almost 7% of the patients who underwent surgery and 39.6% who had radiotherapy had local recurrences. Recurrences in the neck were seen in 16.4% of the patients who underwent surgery and in 10.5% of those who had radiotherapy. Distant metastases were diagnosed only in patients who underwent surgery (4.6%). The 5-year actuarial overall survival rates were 56.3% in the surgical group and 35.2% in the radiotherapy group (P = .007). Age involvement of pyriform sinus, N stage, and history of tracheostomy were independent prognostic factors for risk of death.

CONCLUSIONS: The presence of metastatic lymph nodes, age, and involvement of the pyriform sinus were the important prognostic factors in patients who underwent surgery. A small group of patients with T3,N0,M0 tumors could benefit from radiotherapy, with surgery reserved for recurrence.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты